HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice.

Abstract
Complement receptor 2-deficient (Cr2(-/-)) mice are resistant to mesenteric ischemia/reperfusion (I/R) injury because they lack a component of the natural Ab repertoire. Neither the nature of the Abs that are involved in I/R injury nor the composition of the target Ag, to which recognition is lacking in Cr2(-/-) mice, is known. Because anti-phospholipid Abs have been shown to mediate fetal growth retardation and loss when injected into pregnant mice, we performed experiments to determine whether anti-phospholipid Abs can also reconstitute I/R injury and, therefore, represent members of the injury-inducing repertoire that is missing in Cr2(-/-) mice. We demonstrate that both murine and human monoclonal and polyclonal Abs against negatively charged phospholipids can reconstitute mesenteric I/R-induced intestinal and lung tissue damage in Cr2(-/-) mice. In addition, Abs against beta2 glycoprotein I restore local and remote tissue damage in the Cr2(-/-) mice. Unlike Cr2(-/-) mice, reconstitution of I/R tissue damage in the injury-resistant Rag-1(-/-) mouse required the infusion of both anti-beta2-glycoprotein I and anti-phospholipid Ab. We conclude that anti-phospholipid Abs can bind to tissues subjected to I/R insult and mediate tissue damage.
AuthorsSherry D Fleming, Ryan P Egan, Chunyan Chai, Guillermina Girardi, V Michael Holers, Jane Salmon, Marc Monestier, George C Tsokos
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 173 Issue 11 Pg. 7055-61 (Dec 01 2004) ISSN: 0022-1767 [Print] United States
PMID15557203 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Anticardiolipin
  • Antibodies, Antiphospholipid
  • Antibodies, Monoclonal
  • Glycoproteins
  • Homeodomain Proteins
  • Immune Sera
  • Receptors, Complement 3b
  • Receptors, Complement 3d
  • beta 2-Glycoprotein I
  • RAG-1 protein
Topics
  • Animals
  • Antibodies, Anticardiolipin (administration & dosage, therapeutic use)
  • Antibodies, Antiphospholipid (administration & dosage, metabolism, therapeutic use)
  • Antibodies, Monoclonal (administration & dosage, metabolism, therapeutic use)
  • Female
  • Glycoproteins (immunology, metabolism)
  • Homeodomain Proteins (genetics)
  • Humans
  • Immune Sera (administration & dosage)
  • Infusions, Intravenous
  • Intestinal Mucosa (blood supply, immunology, pathology)
  • Lung (immunology, pathology)
  • Male
  • Mesenteric Arteries
  • Mice
  • Mice, Knockout
  • Receptors, Complement 3b (deficiency, genetics, physiology)
  • Receptors, Complement 3d (deficiency, genetics, physiology)
  • Reperfusion Injury (genetics, immunology, prevention & control)
  • beta 2-Glycoprotein I

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: